HIGHLIGHTS
- who: November and colleagues from the Ageing, India Cardiovascular Medicine, University of California, Riverside, Riverside, CA, United States, Department have published the research work: Impact of uvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study, in the Journal: (JOURNAL)
- what: The study showed similar results in larger cohort of patients seeking early care mostly during the waves of beta, gamma, and delta when vaccines were not available. The study showed a significant mortality and hospitalization benefit among patients who completed treatment with fluvoxamine.
- how: The authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.